Bowel cancer: Alan Titchmarsh urges public to do screening test Dad-of-two Steve Hollington, of Warrington, Cheshire, felt like he won the “lottery ticket” when a…
STDs continue to climb in the US
Sexually transmitted infections (STIs) are surging in the United States, with notable increases seen in case counts of syphilis, gonorrhea and chlamydia. Overall, STIs grew…
Hormone may predict ability to maintain weight loss
Today, in many countries, half of the population is overweight, and the number is increasing. Many people successfully lose weight. The hard part is maintaining…
Study to measure the impact of whole genome sequencing in patients with cardiovascular disease
Henry Ford Health research teams are launching a series of clinical studies in partnership with Illumina Inc., a global leader in DNA sequencing and array-based…
Olaparib approved for 800 prostate and breast cancer patients in England
Who is olaparib now recommended for? HER2-negative breast cancer patients with high-risk, early-stage disease, after chemotherapy and surgery. This group includes people with hormone receptor-positive…
A New CDC Report Shows STIs Are on the Rise — Here Are the Complicated Reasons Why
Rates of sexually transmitted infections (STIs) are on the rise in America, according to new data from the Centers for Disease Control and Prevention (CDC).…
Financial toxicity of cancer impacts partners quality of life, says study
A cancer diagnosis can cause financial strain on patients as they cope with the cost of treatment and lost work. But what about their partners?…
TikTok claims this fruit cures constipation and stomach problems
TikTok claims this fruit cures constipation and stomach problems — so is it really a superfood? Over 110 million people have viewed a TikTok trend…
New therapy harnesses patients blood cells to fight tumors
Adoptive cell therapy (ACT) has become a promising immunotherapy tool to help treat advanced melanoma. The therapy, which harnesses immune cells collected from the patient’s…
Scientists isolate two antibodies that neutralize all current SARS-CoV-2 variants of concern
In a recent study on the bioRxiv preprint server, researchers found antibodies that neutralize all current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of…